Alere Inactive 10-K2009 FY Annual report

Filed: 1 Mar 10, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Abingdon, accrual, adoptedThe, AMT, animal, Apollo, appeal, Argentina, Argentinean, art, ASC, ASUNo, authoritative, aware, bedside, Beijing, Belfast, Belgium, bid, Biolinker, biological, Biosyn, cancellation, Caremark, Carolina, Chain, Chapel, clarification, clarify, CLIA, climate, CoagClinic, CoagNow, Codification, cognitive, competitor, Compliant, compromised, Concateno, convergence, copy, counseling, counterclaim, DDS, defect, deliverable, discovered, dynamic, dynamically, East, Eastern, electrolyte, engine, epoc, Epocal, feel, forensic, frequency, gas, GeneCare, globe, greatly, Gretna, Gurgaon, HCV, healthy, hearing, Hill, HITECH, hope, hub, impending, inequitable, interact, interactive, Irish, isolation, Italia, Jinsung, jointly, JSM, kidney, Korea, Korean, Kroll, Latin, lawsuit, layered, leaseback, legacy, lending, library, Livermore, Louisiana, marker, maximize, Medim, Meditech, Mental, menu, message, misuse, Mologic, mortgage, motion, movement, NGAL, orderly, outbreak, Pakistan, PIMA, poor, popular, proficiency, published, real, redefining, reexamination, repair, replicated, resell, residual, revalue, rich, Richmond, rolled, room, SAMHSA, Schweiz, SD, segregated, Seoul, Sharnbrook, smoking, sophisticated, stamp, standalone, stayed, surrendered, tactical, Taipei, Taiwan, Taiwanese, Tapestry, technique, tobacco, Topic, touch, transferor, trial, trimester, tumor, unconditionally, undue, unenforceable, unparalleled, unpredictable, unproven, UpdateNo, vendor, Virginia, wrote, Yongin, Zug, zycare

Removed: absent, acid, add, added, advent, advertised, age, aging, Alencon, ALLBEE, AMEX, APB, ApS, ARB, assortment, attained, auction, began, bidder, BioPharm, bulk, Bulletin, BVBA, calcium, Carol, CDIL, challenged, Chembio, Chinese, chip, clondiag, commentary, Conversely, cover, cut, declined, demonstrated, dietary, display, distinct, drastically, EITFNo, elimination, Emerging, encouraged, evidenced, exiting, factory, feature, FIN, formal, formulaic, formulation, frequent, FSP, Galway, GlaxoSmithKline, GMP, Goldberg, good, housed, indefinite, Interbank, internet, interpretation, investigation, iron, Irvington, IssueNo, John, Khederian, Levy, liquid, London, lowest, media, Micro, mineral, multiplexing, nucleic, objective, older, origination, outpaced, owner, partner, passed, Perrigo, Pharmavite, Posture, precisely, print, promulgated, protecting, Protegra, Quelch, ratably, ratified, recourse, regional, regulate, remeasurement, rented, retirement, retroactively, reverse, SAB, satisfaction, Scandinavian, settle, shifting, side, slightly, SMB, softgel, SoyCare, spouse, spur, staffing, store, Task, Thermo, treated, trending, unaffiliated, underdeveloped, underpin, undertaken, underwriting, underwritten, utilization, vitamin, warehouse, Wyeth, Yavne, yielded

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Alere similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

Inverness Medical Innovations, Inc. and subsidiaries
Waltham, Massachusetts

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-85658, 333-87180, 333-102577, 333-107288, 333-110715, 333-110716, 333-116659, 333-124461, 333-128017, 333-134412, 333-134574, 333-138889, 333-138919, 333-145249 and 333-158542), and Form S-8 (Nos. 333-67392, 333-74032, 333-85402, 333-90530, 333-106996, 333-106994 and 333-128937, 333-139878, 333-144258, 333-145893, 333-147242, 333-147585, 333-148573, 333-149264, 333-150793, 333-152362, 333-160279, 333-160280 and 333-161373) of Inverness Medical Innovations, Inc. and subsidiaries of our reports dated February 26, 2010, relating to the consolidated financial statements and our report on the effectiveness of Inverness Medical Innovations, Inc. and subsidiaries’ internal control over financial reporting, dated February 26, 2010, which appear in the Company’s Annual Report on Form 10-K for the year ended December 31, 2009.

/s/ BDO Seidman, LLP

Boston, Massachusetts
February 26, 2010